The Global Emtricitabine/Tenofovir Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. Emtricitabine/tenofovir, sold under the trade name Truvada, is a fixed-dose combination antiretroviral drug used for the treatment and prevention of HIV/AIDS. It contains the antiretroviral drugs emtricitabine and tenofovir disoproxil. It should be used in combination with […]
